Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/6/2007
 
First Published:
9/23/2005
1.
Phase I/II Study of Nelfinavir Mesylate in Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
NCI
CHNMC-04090
NCT00233948
Last Modified:
5/22/2008
 
First Published:
12/24/2007
2.
Phase I/II Study of Nelfinavir Mesylate in Combination With Concurrent Thoracic Radiotherapy, Cisplatin, and Etoposide in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
UPCC-806285
806285, UPCC-04507, NCT00589056
3.
Nelfinavir, a Phase I/Phase II Rectal Cancer Study
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Other
MEC 07-03-026
NCT00704600
4.
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
Other
200802788
NCT00791336
Last Modified:
11/24/2008
 
First Published:
2/12/2007
5.
Phase I Study of Nelfinavir Mesylate in Patients With Metastatic, Refractory, or Recurrent Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
NCI-07-C-0047
NCI-P6880, NCT00436735
First Published:
6/24/2008
6.
Phase I Study of Neoadjuvant Therapy Comprising Hypofractionated Stereotactic Radiotherapy and Concurrent Nelfinavir in Combination With Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Patients With Locally Advanced Pancreatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
19 and over
NCI
UNMC-44107
441-07, UNMC-441-07-FB, NCT00705393
7.
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Approved-not yet active
18 to 65
Other
07-09-04/07
EudraCT number 2008-001078-34, NCT00694837
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute